The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of KRAS codon 13 mutations to predict response to neoadjuvant chemoradiation therapy in patients with rectal adenocarcinoma.
Marjun Philip Duldulao
No relevant relationships to disclose
Wendy Lee
No relevant relationships to disclose
Zhenbin Chen
No relevant relationships to disclose
Wenyan Li
No relevant relationships to disclose
Rebecca A. Nelson
No relevant relationships to disclose
Joseph Kim
No relevant relationships to disclose
Julio Garcia-Aguilar
No relevant relationships to disclose